Retraction
miR-30a-5p Regulates Viability, Migration, and Invasion of Lung Adenocarcinoma Cells via Targeting ECT2
Paper Information
Record ID:
56601
Author(s):
Publication Date:
July 07, 2021
Retraction Date:
September 27, 2023
(2.2 years years ago)
Subjects:
Specific Fields:
Biology - Cancer Biology - Cellular Genetics Medicine - Oncology Medicine - Pulmonology
Biology - Cancer Biology - Cellular Genetics Medicine - Oncology Medicine - Pulmonology
Institutions:
- Department of Pharmacy, The Children’s Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310000, China
- Department of Gastroenterology, Taizhou Municipal Hospital, Taizhou 318000, China
- Department of Respiratory Medicine, Taizhou Municipal Hospital, Taizhou 318000, China
- Department of Respiratory Medicine, Affiliated Hospital of Shaoxing University, Shaoxing 312000, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
- Concerns/Issues About Data
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues with Peer Review
- Investigation by Journal/Publisher
- Investigation by Third Party
- Paper Mill
- Computer-Aided Content or Computer-Generated Content
- Unreliable Results and/or Conclusions
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9852617Citations (10)
10
Total Citations2
Post-Retraction(20.0%)
8
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
1
Within 1 year
0
After 2+ years
650
Days since retraction (latest)
Investigating miR-30a′s tumor suppressor role and its targets (MYBL2, TWF1, GALNT7, PFN2) as prognostic biomarkers in lung adenocarcinoma
Yunus Sahin, Zekiye Altan, Khandakar A.S.M. Saadat et al. (5 authors)
Biochemistry and Biophysics Reports
Published: Jul 2025
650 days after retraction
miRNAs and exosomal miRNAs in lung cancer: New emerging players in tumor progression and therapy response
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Mehrnaz Kalhor Chegini et al. (15 authors)
Pathology - Research and Practice
Published: Oct 2023
6 citations
6 citations
30 days after retraction
Potential roles of exosomes in the initiation and metastatic progression of lung cancer
Hongyuan Liang, Lingyun Zhang, Jian Rong
Biomedicine & Pharmacotherapy
Open Access
Published: Aug 2023
4 citations
4 citations
51 days before retraction
The mitotic spindle-related seven-gene predicts the prognosis and immune microenvironment of lung adenocarcinoma
Ruxin Shen, Zhaoshui Li, Xiaoting Wu
Journal of Cancer Research and Clinical Oncology
Open Access
Published: Jun 2023
5 citations
5 citations
117 days before retraction
MiRNA-30a-5p/VCAN Arrests Tumor Metastasis via Modulating the Adhesion of Lung Adenocarcinoma Cells
Enqiang Qin, Shuojia Gu, Yimin Guo et al. (5 authors)
Applied Biochemistry and Biotechnology
Published: Apr 2023
4 citations
4 citations
170 days before retraction
TTYH3 is a Prognostic Biomarker and Associates with Immune Cell Infiltrations of Lung Adenocarcinoma
Jian Xu, Jiming Chen, Honglu Duan et al. (7 authors)
International Journal of Morphology
Open Access
Published: Feb 2023
238 days before retraction
Retracted: miR‐30a‐5p Regulates Viability, Migration, and Invasion of Lung Adenocarcinoma Cells via Targeting ECT2
Computational and Mathematical Methods in Medicine
Computational and Mathematical Methods in Medicine
Open Access
Published: Jan 2023
269 days before retraction
High expression levels of FANCI correlate with worse prognosis and promote tumor growth of lung adenocarcinoma partly via suppression of M1 macrophages
Wujin Li, Mingdian Yu, Jiguang Zhang et al. (8 authors)
Gene
Published: Nov 2022
5 citations
5 citations
317 days before retraction
lncRNA DLEU2 Accelerates Oral Cancer Progression via miR-30a-5p/RAP1B Axis to Regulate p38 MAPK Signaling Pathway
Wenbo Zhang, Yanchun Wang, Pu Xu et al. (5 authors)
Disease Markers
Open Access
Published: Oct 2022
7 citations
7 citations
350 days before retraction
High level of FANCI correlates with worse prognostic outcome and promotes tumor growth of lung adenocarcinoma partly by suppressing the activation of M1 macrophages
Wujin Li, Mingdian Yu, Jiguang Zhang et al. (8 authors)
Research Square (Research Square)
Open Access
Published: Aug 2022
406 days before retraction
Quick Stats
Total Citations:
10
Years Since Retraction:
2.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025